- $358.21bn
- $405.02bn
- $65.01bn
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Merck's Keytruda Qlex Approved In Japan For Subcutaneous Administration For All Keytruda Indications Approved In Japan
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
U.S. STOCKS ON THE MOVE-GitLab, California utilities, Herbalife
U.S. STOCKS ON THE MOVE-Kaiser Aluminum, EPAM Systems, software stocks
U.S. STOCKS ON THE MOVE-Science Applications, GameStop, Aon PLC
U.S. STOCKS ON THE MOVE-Pinterest, Intel, SLB
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
Moderna rises after upsized $2.6 bln convertible bond sale
Focus: Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
Moderna falls after unveiling $2 bln convertible debt plans
US STOCKS-Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
US STOCKS-Indexes end close to flat after hot inflation data ahead of Nvidia earnings
US STOCKS-Wall Street dips on hot inflation data ahead of Nvidia earnings